Stockscreener 앱 받기
0.3739
0.29%
-0.0011
시간 외 거래:
.37
-0.0039
-1.04%
Soligenix Inc 주식(SNGX)의 최신 뉴스
Soligenix Inc (SNGX) Cash Flow - TradingKey
Soligenix Inc (SNGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Soligenix Inc (SNGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Soligenix Inc (SNGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Soligenix Inc (SNGX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Soligenix Inc (SNGX) Institutional Confidence - TradingKey
Soligenix Inc (SNGX) Income Statement - TradingKey
SNGX|Soligenix Inc|Price:0.371|Chg%:-0.002 - TradingKey
Soligenix, Inc. Revenue Breakdown – NASDAQ:SNGX - TradingView
Soligenix (SNGX) seeks reverse stock split and higher authorized shares - Stock Titan
Soligenix (SNGX) Q1 2026 Earnings: Narrower-than-expected net loss per share amid steady pipeline advancement - dars.gov.et
SNGX News | SOLIGENIX INC (NASDAQ:SNGX) - ChartMill
Soligenix (SNGX) seeks reverse stock split, higher share authorization to protect Nasdaq listing - Stock Titan
Soligenix Inc. (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Continued Pipeline Progress - dars.gov.et
Soligenix (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Development ContinuesAnnual Earnings Summary - dars.gov.et
SNGX Stock Price, Quote & Chart - ChartMill
Soligenix Q1 2026 Earnings: Narrower-than-Expected Loss Reflects Cost ManagementAnalyst Drop Coverage - dars.gov.et
Soligenix (SNGX) Q1 2026 Earnings: Small EPS Beat Amid Continued Pipeline ProgressEstimate Dispersion - dars.gov.et
Soligenix, Inc. Financial Disclosures & SEC Filings - TradingView
Soligenix Expands At-the-Market Equity Offering Capacity - The Globe and Mail
SNGX Stock Slumps To Record Low After Lymphoma Trial Fails – All Eyes Now On Behçet’s Disease Treatment - Stocktwits
Form 424B5 Soligenix Inc For: 26 June - Investing.com UK
Form 424B5 Soligenix Inc For: 26 June By Investing.com - Investing.com Nigeria
Soligenix ups ATM offering by $2.5M under Rodman & Renshaw agreement - TradingView
Soligenix (NASDAQ: SNGX) adds $2.5M to at-the-market stock program - Stock Titan
Soligenix (NASDAQ: SNGX) resets ATM capacity to $2.5M under S-3 - Stock Titan
Michael Liu, MJL Manager (SNGX) disclose 983,588 shares; related group holds material blocks - Stock Titan
Soligenix, Inc. Actuals & Estimates (NASDAQ:SNGX) - TradingView
SNGX Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Soligenix, Inc. – NASDAQ:SNGX - TradingView
Price to earnings forward of Soligenix, Inc. – NASDAQ:SNGX - TradingView
SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month On Ebola Vaccine Optimism - Stocktwits
Soligenix (SNGX) Slips 2.31% as Stock Nears Key Support at $0.36Ichimoku Entry - po-news-eg.net
Soligenix Q1 2026 Earnings: Narrower Loss Beats Expectations, No Revenue ReportedBasic EPS Analysis - DonanımHaber
Soligenix Inc (SNGX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Soligenix (SNGX) stock soars 72% on ThermoVax platform promise amid Ebola outbreak caused by Bundibugyo virus - MSN
Soligenix Inc. (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesTax Rate Impact - newsline.com
Soligenix Inc (SNGX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Soligenix Inc (SNGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Soligenix Inc (SNGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock ReactionEstimate Revision Count - dars.gov.et
Soligenix Q1 2026 Earnings: Narrower-Than-Expected Loss as EPS Beats EstimatesRevenue Breakdown Analysis - newsline.com
Soligenix (SNGX) Hovers Near Key Support After Modest DeclineBearish Pattern Stocks - newsline.com
Soligenix Halts HyBryte Program, Refocuses Pipeline Strategy - TipRanks
Soligenix's Richard C. Straube ceases Consulting CMO role; duties moved to Christopher Pullion - TradingView
Soligenix (NASDAQ: SNGX) faces Nasdaq bid-price risk and ends HyBryte program - Stock Titan
SNGX Q1 2026 Earnings: EPS Beat Amid No Revenue, Stock DeclinesGross Profit Margin - newsline.com
Soligenix Received Notice of Noncompliance - TradingView
Soligenix (SNGX) Bounces From Support: Biotech Stock Rises 3.5% to $0.44IV Contraction - newsline.com
Soligenix Stock Short Interest Rises to 43.99% - Quiver Quantitative
Soligenix(SNGX) Stock Options Chain | Quotes & News - Moomoo
Soligenix Seeks Funding for Bundibugyo Ebola Vaccine - AllSci
SNGX Q1 2026 Earnings: Narrower Loss Than Anticipated as Biotech Advances PipelineManagement Guidance Update - newsline.com
Soligenix Announces Recent Accomplishments And Third Quarter 202 - GuruFocus
Soligenix (SNGX) Pursues Vaccine Development for Bundibugyo Viru - GuruFocus
Soligenix applies for CEPI funding to develop thermostable vaccine for Bundibugyo Ebola virus. - Pluang
2.44%
0.02%
자본화:
|
볼륨(24시간):